AMD 3465 hexahydrobromide
作者：齐岳
发布时间：2023-09-12
09:09:44
点击数：
产品名称：AMD 3465 hexahydrobromide
产品描述：
| 产品描述 | AMD 3465 hexahydrobromide is a CXCR4 receptor antagonist with potential anticancer and anti-HIV activity. |
| 靶点活性 | X4 HIV-1 (NL4.3AMD3100):2822 nM (IC50, in MT-4 cells), X4 HIV-1 (IIIB):12.3 nM (IC50, in MT-4 cells), X4 HIV-1 (RF):7.4 nM (IC50, in MT-4 cells), 12G5 mAb-CXCR4:0.75 nM (IC50, in SupT1 cells), HIV-2 (ROD):12.3 nM (IC50, in MT-4 cells), CXCL12AF647-CXCR4:18 nM (IC50, in SupT1 cells), X4 HIV-1 (HE):9.8 nM (IC50, in MT-4 cells), HIV-2 (EHO):12.3 nM (IC50, in MT-4 cells), X4 HIV-1 (NL4.3):6.1 nM (IC50, in MT-4 cells) |
| 体外活性 | AMD 3465 hexahydrobromide inhibits binding of 12G5 mAb and CXCL12AF647 to CXCR4, with IC50s of 0.75 nM and 18 nM in SupT1 cells.?AMD 3465 (50 nM) totally blocks CXCL12-induced calcium mobilization, with an IC50 of 17 nM, but shows no effect on the intracellular calcium fluxes elicited by the CCR5 ligands RANTES, LD78β and MIP-1β in U87.CD4.CCR5 cells.?AMD 3465 also potently inhibits the replication of X4 HIV strains (IC50: 1-10 nM), but has no effect on CCR5-using (R5) viruses.?AMD3465 is cytotoxic to the X4 HIV-1 strains IIIB, NL4.3, RF and HE with an IC50 ranging from 6 to 12 nM.?The IC50 for suppression of the HIV-2 strains ROD and EHO is 12.3 nM[1].?AMD 3465 inhibits CXCL-12-induced growth in U87 and Daoy cells.?AMD 3465 treatment stimulates the phosphorylation of Erk1/2 in U87 and Daoy cells[2]. |
| 体内活性 | AMD 3465 with 2.5 mg/kg/d, s.c. for 5 weeks significantly blocks the growth of U87 GBM and Daoy xenografts[2] |
| 别名 | GENZ-644494 (hexahydrobromide) |
| 分子量 | 896.07 |
| 分子式 | C24H44Br6N6 |
| CAS No. | 185991-07-5 |
存储
Powder: -20°C for 3 years | In solvent: -80°C for 2 years
溶解度
H2O: 38 mg/mL (42.41 mM)
DMSO: 50 mg/mL (55.80 mM),Need ultrasonic
( < 1 mg/mL refers to the product slightly soluble or insoluble )
联系我们：
邮箱：2519696869@qq.com
QQ: 2519696869
电话：18066853083
微信：18066853083
公司介绍：
西安齐岳生物科技有限公司是集化学科研和定制与一体的高科技化学公司。业务范围包括化学试剂和产品的研发、生产、销售等。涉及产品为通用试剂的分销、非通用试剂的定制与研发，涵盖生物科技、化学品、中间体和化工材料等领域。
主营产品：COF、MOF单体系列：三蝶烯衍生物、金刚烷衍生物、四苯甲烷衍生物、peg、上转换、石墨烯、光电材料、点击化学、凝集素、载玻片、蛋白质交联剂、脂质体、蛋白、多肽、氨基酸、糖化学等。
